Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban versus placebo after hospitalization for worsening chronic heart failure with coronary artery disease
2013-000046-19Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic heart failure (CHF) and coronary arteriosclerosis comparing Rivaroxaban plus standard care with Placebo plus standard care (2 arms). Started Jun 2013; status: completed.
02
Drugs
rivaroxaban
03
Conditions
chronic heart failure (CHF)coronary arteriosclerosis
Beyond the preview
Go deeper on 2013-000046-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000046-19.